These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32655123)
1. [Multimodal therapy improved carcinoid syndrome secondary to liver metastases of an atypical lung carcinoid tumor:a case report]. Shimizu T; Adikrisna R; Shimada K; Uchidate K; Fukuda K; Oyama A; Ueda M; Goto F; Suzuki M; Kawamura T Nihon Shokakibyo Gakkai Zasshi; 2020; 117(7):635-645. PubMed ID: 32655123 [TBL] [Abstract][Full Text] [Related]
2. Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report. Kałuzny M; Bolanowski M; Sukiennik-Kujawa M; Ponikowski P; Handkiewicz-Junak D; Jarzab B; Jawiarczyk A; Syrycka J Endokrynol Pol; 2009; 60(5):401-6. PubMed ID: 19885812 [TBL] [Abstract][Full Text] [Related]
4. [Successful treatment of carcinoid syndrome in two cases of bronchial carcinoid]. Katakami N; Matsumoto H; Ishihara K; Umeda B Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1313-8. PubMed ID: 8583728 [TBL] [Abstract][Full Text] [Related]
5. Everolimus in combination with octreotide LAR in thymic atypical carcinoid. Sakane T; Nakano T; Hagui E; Haneda H; Okuda K Thorac Cancer; 2023 May; 14(15):1404-1407. PubMed ID: 37037489 [TBL] [Abstract][Full Text] [Related]
6. [A case of rectal carcinoid with multiple liver, lymph nodes and bone metastases that responded to an octreotide therapy]. Yamashita K; Takase S; Nakamura T; Matsuda Y; Imanishi T; Sumi Y; Suzuki S; Kamigaki T; Ku Y; Kuroda D Gan To Kagaku Ryoho; 2010 Nov; 37(12):2349-51. PubMed ID: 21224569 [TBL] [Abstract][Full Text] [Related]
7. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management. Claure RE; Drover DD; Haddow GR; Esquivel CO; Angst MS Can J Anaesth; 2000 Apr; 47(4):334-7. PubMed ID: 10764178 [TBL] [Abstract][Full Text] [Related]
8. [The scintigraphy of somatostatin receptors in the carcinoid tumor]. Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324 [TBL] [Abstract][Full Text] [Related]
9. Metastatic thymic carcinoid responds to chemoradiation and octreotide: A case report. Mei Z; Wang H; Ren S; Wei J; Gu Y Medicine (Baltimore); 2018 Nov; 97(47):e13286. PubMed ID: 30461637 [TBL] [Abstract][Full Text] [Related]
10. Infection with multidrug-resistant Campylobacter coli mimicking recurrence of carcinoid syndrome: a case report of a neuroendocrine tumor patient with repeated diarrhea. Lagler H; Kiesewetter B; Raderer M BMC Infect Dis; 2016 Aug; 16():409. PubMed ID: 27519265 [TBL] [Abstract][Full Text] [Related]
11. Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide. Filosso PL; Ruffini E; Oliaro A; Papalia E; Donati G; Rena O Eur J Cardiothorac Surg; 2002 May; 21(5):913-7. PubMed ID: 12062286 [TBL] [Abstract][Full Text] [Related]
12. The importance of follow-up examinations in patients with carcinoid tumor. Szilvás A; Székely G; Szilvási I; Sági S; Jakab F Hepatogastroenterology; 2003; 50(53):1452-3. PubMed ID: 14571761 [TBL] [Abstract][Full Text] [Related]
13. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis. Condron ME; Pommier SJ; Pommier RF Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846 [TBL] [Abstract][Full Text] [Related]
14. Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). Davì MV; Bodei L; Francia G; Bartolomei M; Oliani C; Scilanga L; Reghellin D; Falconi M; Paganelli G; Lo Cascio V; Ferdeghini M J Endocrinol Invest; 2006 Jun; 29(6):563-7. PubMed ID: 16840837 [TBL] [Abstract][Full Text] [Related]
15. Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues. Wolin EM; Jarzab B; Eriksson B; Walter T; Toumpanakis C; Morse MA; Tomassetti P; Weber MM; Fogelman DR; Ramage J; Poon D; Gadbaw B; Li J; Pasieka JL; Mahamat A; Swahn F; Newell-Price J; Mansoor W; Öberg K Drug Des Devel Ther; 2015; 9():5075-86. PubMed ID: 26366058 [TBL] [Abstract][Full Text] [Related]
16. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients. Massimino K; Harrskog O; Pommier S; Pommier R J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524 [TBL] [Abstract][Full Text] [Related]